skip to main content
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refinado por: Nome da Publicação: British Journal Of Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
Material Type:
Artigo
Adicionar ao Meu Espaço

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

FRANCIS, R. J ; SHARMA, S. K ; O'MALLEY, D ; TSIOMPANOU, E ; SHAHBAKHTI, H ; WEBLEY, S ; HOCHHAUSER, D ; HILSON, A. J ; BLAKEY, D ; BEGENT, R. H. J ; SPRINGER, C ; GREEN, A. J ; HOPE-STONE, L. D ; SENA, L ; MARTIN, J ; ADAMSON, K. L ; ROBBINS, A ; GUMBRELL, L

British journal of cancer, 2002-09, Vol.87 (6), p.600-607 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

2
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
Material Type:
Artigo
Adicionar ao Meu Espaço

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)

MAYER, A ; SHARMA, S. K ; TOLNER, B ; MINTON, N. P ; PURDY, D ; AMLOT, P ; THARAKAN, G ; BEGENT, R. H. J ; CHESTER, K. A

British journal of cancer, 2004-06, Vol.90 (12), p.2402-2410 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

3
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy
Material Type:
Artigo
Adicionar ao Meu Espaço

A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

DECKERT, P. M ; RENNER, C ; COHEN, L. S ; JUNGBLUTH, A ; RITTER, G ; BERTINO, J. R ; OLD, L. J ; WELT, S

British journal of cancer, 2003-03, Vol.88 (6), p.937-939 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

4
Recent developments in the design of bioreductive drugs
Material Type:
Artigo
Adicionar ao Meu Espaço

Recent developments in the design of bioreductive drugs

Denny, W A ; Wilson, W R ; Hay, M P

British journal of cancer. Supplement, 1996-07, Vol.27, p.S32-S38 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

5
Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
Material Type:
Artigo
Adicionar ao Meu Espaço

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)

MONKS, N. R ; CALVETE, J. A ; CURTIN, N. J ; BLAKEY, D. C ; EAST, S. J ; NEWELL, D. R

British journal of cancer, 2000-07, Vol.83 (2), p.267-269 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

6
Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme : its effect on prodrug activation in vivo
Material Type:
Artigo
Adicionar ao Meu Espaço

Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme : its effect on prodrug activation in vivo

ROGERS, G. T ; BURKE, P. J ; SHARMA, S. K ; KOODIE, R ; BODEN, J. A

British journal of cancer, 1995-12, Vol.72 (6), p.1357-1363 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.